Hyperfine (HYPR) Competitors

$0.87
-0.01 (-1.14%)
(As of 05/15/2024 ET)

HYPR vs. MOVE, ECOR, PXDT, POCI, NRXS, VANI, QTI, BSGM, FONR, and ELMD

Should you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Movano (MOVE), electroCore (ECOR), Pixie Dust Technologies (PXDT), Precision Optics (POCI), NeurAxis (NRXS), Vivani Medical (VANI), QT Imaging (QTI), BioSig Technologies (BSGM), FONAR (FONR), and Electromed (ELMD). These companies are all part of the "electromedical equipment" industry.

Hyperfine vs.

Hyperfine (NASDAQ:HYPR) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.

Hyperfine currently has a consensus target price of $2.12, suggesting a potential upside of 140.26%. Given Hyperfine's higher possible upside, analysts plainly believe Hyperfine is more favorable than Movano.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Movano
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Hyperfine has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500.

In the previous week, Movano had 17 more articles in the media than Hyperfine. MarketBeat recorded 26 mentions for Movano and 9 mentions for Hyperfine. Movano's average media sentiment score of 0.45 beat Hyperfine's score of 0.44 indicating that Movano is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Movano
6 Very Positive mention(s)
6 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Movano received 179 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 70.66% of users gave Movano an outperform vote while only 44.44% of users gave Hyperfine an outperform vote.

CompanyUnderperformOutperform
HyperfineOutperform Votes
4
44.44%
Underperform Votes
5
55.56%
MovanoOutperform Votes
183
70.66%
Underperform Votes
76
29.34%

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 16.6% of Movano shares are owned by institutional investors. 26.5% of Hyperfine shares are owned by insiders. Comparatively, 8.6% of Movano shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Movano has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Movano, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.03M5.68-$44.24M-$0.59-1.47
MovanoN/AN/A-$29.28M-$0.65-0.72

Movano has a net margin of 0.00% compared to Hyperfine's net margin of -358.59%. Hyperfine's return on equity of -44.69% beat Movano's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-358.59% -44.69% -40.59%
Movano N/A -361.91%-215.55%

Summary

Hyperfine and Movano tied by winning 8 of the 16 factors compared between the two stocks.

Get Hyperfine News Delivered to You Automatically

Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HYPR vs. The Competition

MetricHyperfineElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$62.60M$3.30B$5.09B$7.98B
Dividend YieldN/A1.67%37.04%3.93%
P/E Ratio-1.478.58133.1916.61
Price / Sales5.6867.242,304.0879.20
Price / CashN/A67.2835.7831.18
Price / Book0.744.225.494.47
Net Income-$44.24M$87.99M$104.75M$216.86M
7 Day Performance8.71%3.63%1.13%1.99%
1 Month Performance-13.43%-0.49%2.63%4.35%
1 Year Performance-37.86%5.01%6.60%10.80%

Hyperfine Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOVE
Movano
0 of 5 stars
$0.45
flat
N/A-58.5%$44.41MN/A-0.7034Gap Down
ECOR
electroCore
0.6881 of 5 stars
$7.02
+0.3%
N/A+10.2%$42.12M$16.03M-1.9768Short Interest ↓
News Coverage
Gap Up
High Trading Volume
PXDT
Pixie Dust Technologies
2.7694 of 5 stars
$2.62
-0.4%
$5.21
+98.9%
N/A$38.51M$5.18M0.0078Gap Up
POCI
Precision Optics
0 of 5 stars
$5.64
-0.2%
N/A+2.3%$34.24M$21.05M-18.8084News Coverage
NRXS
NeurAxis
0 of 5 stars
$3.08
-0.6%
N/AN/A$20.30M$2.46M-0.6717News Coverage
VANI
Vivani Medical
0 of 5 stars
$1.73
-3.4%
N/A+46.9%$95.11MN/A-3.4644Upcoming Earnings
Short Interest ↑
QTI
QT Imaging
0 of 5 stars
$0.79
flat
N/AN/A$16.94MN/A0.00N/APositive News
Gap Up
BSGM
BioSig Technologies
0 of 5 stars
$1.33
-6.3%
N/A-88.6%$14.90M$20,000.00-0.284Upcoming Earnings
Gap Down
FONR
FONAR
0 of 5 stars
$17.15
-2.6%
N/A-2.3%$108.56M$98.64M9.32561Upcoming Earnings
Short Interest ↑
News Coverage
ELMD
Electromed
0 of 5 stars
$17.51
-1.1%
N/A+45.3%$150.76M$48.07M38.91170Analyst Upgrade

Related Companies and Tools

This page (NASDAQ:HYPR) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners